The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Uretron D/S
Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate · SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 40.8 mg/1; PHENYL SALICYLATE 36.2 mg/1; HYOSCYAMINE SULFATE .12 mg/1; METHYLENE BLUE 10.8 mg/1; METHENAMINE 81.6 mg/1 · Tablet · Oral · DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals
NDC 12539-0144-01 · 100 TABLET in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 40.8 mg/1; PHENYL SALICYLATE 36.2 mg/1; HYOSCYAMINE SULFATE .12 mg/1; METHYLENE BLUE 10.8 mg/1; METHENAMINE 81.6 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE .12 mg/1; PHENYL SALICYLATE 81.6 mg/1; HYOSCYAMINE SULFATE 10.8 mg/1; METHYLENE BLUE 36.2 mg/1; METHENAMINE 40.8 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | HYOSCYAMINE SULFATE .12 mg/1; METHENAMINE 81.6 mg/1; METHYLENE BLUE 10.8 mg/1; PHENYL SALICYLATE 36.2 mg/1; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 40.8 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Uretron D/S — NDC 12539-0144-01," retrieved September 3, 2026, https://drugdashboards.com/drug/12539014401.
Free to cite with attribution — see how the data is put together.